jilibay_official

The long-awaited hearing to discuss cannabis rescheduling will begin on January 21, 2025 , marking a significant moment in the ongoing debate over cannabis regulation. As Business of Cannabis reported , the six-week hearing will continue until March 6, 2025 , but its outcome remains uncertain due to political and procedural challenges. With key positions in the new administration still unconfirmed, many questions remain about how much influence the incoming cabinet will have on the hearings. This uncertainty has raised concerns over the DEA’s impartiality and the fairness of the process. Legal Challenges From Health Coalitions And Advocates In a move that has added to the controversy, the Doctors for Drug Policy Reform has filed a federal court petition challenging the DEA's exclusion from the hearings. According to Businnes of Cannabis, the group argues that their medical expertise is essential for evaluating the implications of cannabis rescheduling, particularly regarding medical marijuana prescriptions. Additionally, weeks ago, the agency denied MedPharm's bid to join the December 2 hearing . MedPharm , a DEA-registered research firm, criticized the exclusion of marijuana researchers and the inclusion of prohibitionist organizations such as Smart Approaches to Marijuana (SAM) . SAM has been also at the center of the controversy. On November 28, attorney Matt Zorn sued the DEA for failing to release records related to its communications with the organization. The DEA dismissed them as "gossip," arguing that there was no illegal contact, despite SAM President Kevin Sabet admitting to discussing the details of the rescheduling with DEA insiders. SAM also denied that the conversations had anything to do with the rescheduling procedure. Earlier in November, the Veterans Action Council , a cannabis advocacy organization for military veterans, filed a petition challenging its exclusion from the DEA’s participant list, published in October. The petiton followed the withdrawal of some designated participants and growing scrutiny over the agency's handling of the rescheduling process. Several organizations have pulled out of the hearings since the initial announcement. The American College of Occupational and Environmental Medicine missed important procedural deadlines, while an oncologist representing the American Academy of Hospice and Palliative Medicine opted not to participate. Additionally, five remaining participants are represented by David Evans , a prominent anti-cannabis advocate, highlighting the polarized nature of the upcoming hearings. Scheduled Presentations And Participants The DEA has outlined a strict schedule for the hearings, featuring presentations from various stakeholders, including industry groups, law enforcement and medical professionals. Notable participants include the National Cannabis Industry Association and Smart Approaches to Marijuana , among others. The schedule includes: January 21 : Presentation by the government January 22-23 : Presentations from Hemp for Victory , Cannabis Bioscience International Holdings and other groups January 28-30 : Presentations from the Connecticut Office of the Cannabis Ombudsman , National Cannabis Industry Association and additional participants February 4-6 : Presentations from The Commonwealth Project , Veterans Initiative 22 and others February 18-20 : Presentations from the Tennessee Bureau of Investigation , International Association of Chiefs of Police and more February 25-27 : Presentations from Smart Approaches to Marijuana , Community Anti-Drug Coalitions of America and other stakeholders March 4-6 : Presentations from Dr. Kenneth Finn , N ational Drug and Alcohol Screening Association and others. Public Comments Excluded From the Process Although more than 43,000 public comments were submitted during the 60-day comment period, the DEA has ruled that these comments will not be accepted as evidence, citing the limitations of the Administrative Procedure Act. This decision has generated criticism from cannabis advocates and industry leaders. High Stakes For The Industry Reclassifying marijuana could provide significant advantages to the U.S. cannabis industry . It would ease research and financial restrictions, improve access to banking and reduce legal challenges, enabling businesses to operate more freely. A Schedule III classification could also lead to broader insurance coverage and more federal funding for cannabis research, potentially fostering growth, investment and innovation. Advocates argue that rescheduling would enhance regulation and increase access to medical cannabis, but given the complexities of the process, the final decision may still be months away, with lasting impacts on the industry. Cover image made with AI © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Gavin and Stacey star reveals cast were kept in dark about SECOND plot twist as she lifts lid on top secret filming

Vancouver Canucks general manager Patrik Allvin announced on Tuesday afternoon that defenceman Filip Hronek would be out approximately eight weeks after a successful procedure on his lower body. He also said that Hronek would not need surgery on the upper-body injury that has forced him to miss the last two games. General Manager Patrik Allvin provides an update on Filip Hronek: pic.twitter.com/qKvHAeQnRO Hronek was injured against the Pittsburgh Penguins on Nov. 27 when he was hit into the boards by Jack St. Ivany. He fell awkwardly on his right shoulder and was visibly in pain as he went to the ice. The Canucks did not provide any updates in the days following the game, as head coach Rick Tocchet said that he was still being evaluated . It’s good news that he won’t require surgery on his shoulder since he would have been sidelined the rest of the season if that was the only option. In his absence, the Canucks have elevated Tyler Myers to the top pairing with Quinn Hughes while Erik Brannstrom has taken on a larger role in the top four. Noah Juulsen has also had a regular spot in the lineup over the last two games, highlighted by a gritty effort against the Detroit Red Wings on Sunday (Dec. 1) where he had five blocks and five hits. Vincent Desharnais has also been placed in a second-pairing role alongside Brannstrom while Carson Soucy has been deployed with Juulsen on the bottom pairing. Mark Friedman was recalled as the seventh defenceman on Nov. 29. The Canucks are in Minnesota to take on the Wild later tonight as they close out their six-game road trip. Despite not having Hronek in the last two games, they have strung together two overtime wins and will be looking to head back to Vancouver sporting an 11-2-0 record on the road. This article first appeared on The Hockey Writers and was syndicated with permission.

Florida Sheriff Chad Chronister withdraws from consideration for DEA post

CLEVELAND (AP) — Germain Ifedi became the fourth left tackle to start this season for the Cleveland Browns, lining up Thursday night against the AFC North-leading Pittsburgh Steelers. Ifedi moved up the depth chart and into the lineup after starter Dawand Jones broke his left leg last week at New Orleans and had surgery. He'll be responsible for blocking quarterback Jameis Winston's blindside. Jedrick Wills Jr., who had lost his starting job to Jones, figured to start against the Steelers (8-2), but was ruled out Wednesday with a knee injury that has bothered him for weeks. A first-round pick in 2020, Wills recently caused a stir by saying he made a “business decision” to sit out a game on Oct. 27 against Baltimore because of his knee. Coach Kevin Stefanski said Wills used a “poor choice of words.” James Hudson started Cleveland's first two games at left tackle while the Browns (2-8) waited for Wills to recover from knee surgery in December. The first-place Steelers were without outside linebacker/edge rusher Alex Highsmith, who missed his second straight game with an ankle injury. ___ AP NFL: https://apnews.com/hub/nfl The Associated Press